MHRA and vaccine makers in talks over new Covid variants

Scientists start work on steps needed for potential rapid development of a modified vaccine, AstraZeneca says

The UK medicines regulator is in discussions with coronavirus vaccine manufacturers about “potential modifications” that may be needed to ensure their jabs protect against new variants of the virus.

The Medicines and Healthcare products Regulatory Agency (MHRA) said there was no evidence that vaccines failed to work against the new variants that emerged in recent months, but said it had made the issue a priority.

Continue reading…

Next Post

President Biden and Boris Johnson share hopes for end to Covid in first phone call

Sun Jan 24 , 2021
The 46th US president and the UK prime minister also discussed Nato, climate change and human rights Boris Johnson has had his first call with Joe Biden since the new US president entered the White House on Wednesday. Downing Street said Johnson congratulated Biden on his inauguration and that the […]

You May Like